BIOMAT Database Logo BIOMAT Database Logo

Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex. 1996

K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Department of Physiology & Biophysics, University of Iowa, Iowa City, 52242, USA.

Insulin stimulates the Ras/Raf/MEK/ERK pathway leading to feedback phosphorylation of the Ras guanylnucleotide exchange protein SOS and dissociation of Grb2 from SOS. Even though epidermal growth factor (EGF) also stimulates ERK activity and phosphorylation of SOS similar to insulin, EGF induces a dissociation of the Grb2-SOS complex from Shc. To determine the molecular basis for this difference, we examined the signaling properties of a mutant EGF receptor lacking the five major autophosphorylation sites. Although EGF stimulation of the mutant EGF receptor activates ERK and phosphorylation of both Shc and SOS, it fails to directly associate with either Shc or Grb2. However, under these conditions EGF induces a dissociation of the Grb2-SOS complex suggesting a role for receptor and/or plasma membrane targeting in the stabilization of Grb2-SOS interaction. Consistent with this hypothesis, expression of an SH2 domain Grb2 mutant which is unable to mediate plasma membrane targeting of the Grb2-SOS complex results in both insulin- and EGF-stimulated uncoupling of Grb2 from SOS. Furthermore, a plasma membrane-bound Grb2 fusion protein remains constitutively associated with SOS. Together, these data demonstrate that EGF stimulation prevents the feedback uncoupling of Grb2 from SOS by inducing a persistent plasma membrane receptor targeting of the Grb2-SOS complex.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Arachidonate-induced tyrosine phosphorylation of epidermal growth factor receptor and Shc-Grb2-Sos association.
December 1998, Hypertension (Dallas, Tex. : 1979),
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.
May 1993, Cell,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Epidermal growth factor receptor targeting.
July 1999, IDrugs : the investigational drugs journal,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Targeting the epidermal growth factor receptor.
August 2004, British journal of cancer,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Insulin-stimulated disassociation of the SOS-Grb2 complex.
May 1995, Molecular and cellular biology,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Monoclonal antibodies targeting the epidermal growth factor receptor.
May 2005, Current drug targets,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Epidermal growth factor receptor targeting in cancer.
August 2006, Seminars in oncology,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
GRB2 couples RhoU to epidermal growth factor receptor signaling and cell migration.
June 2011, Molecular biology of the cell,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors.
March 2020, JACC. CardioOncology,
K H Holt, and S B Waters, and S Okada, and K Yamauchi, and S J Decker, and A R Saltiel, and D G Motto, and G A Koretzky, and J E Pessin
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.
August 1994, Molecular and cellular biology,
Copied contents to your clipboard!